Silicon Investor (SI) -- The First Internet Community

STOCKTALK

We've detected that you're using an ad content blocking browser plug-in or feature. Ads provide a critical source of revenue to the continued operation of Silicon Investor. We ask that you disable ad blocking while on Silicon Investor in the best interests of our community. If you are not using an ad blocker but are still receiving this message, make sure your browser's tracking protection is set to the 'standard' level.

Gold/Mining/Energy : Parkcrest Explorations Ltd. - Discovery 4,116 BPD -- Ignore unavailable to you. Want to Upgrade?

To: leaf who wrote (54)	1/1/1998 3:19:00 PM
From: Ed Ajootian	Read Replies (1) \| Respond to of 94

Leaf, HEC going up at this point does not bear very much on PKC IMO. PKC would only go up when good news comes out about the Alcaravan Contract. The well was just spudded 12/15 and will take 45 days so there is no chance that any news could be out on that yet. So the reason HEC is going up has no direct bearing on PKC. Of course it doesn't hurt to be a partner with a billion $$ market cap. company, which is where HEC would be if it goes to $8 or if they issue more stock at the $7 -- $7.50 mark and the price holds up. My thinking if the HEC stock price can get to, say, $8, that HEC may take this opportunity to issue more shares and use the money to buy out PKC and ROH. There are already rumors flying around on this in the ROH thread. While we would probably make more money long-term if we stayed independent it is not bad having the buyout scenario as a saftety net if the stock price never wakes up from the doldrums its in right now. My hunch is that PKC unfortunately is being held hostage by the investors that are participating in its private offering. The investors keep holding out for better terms, but PKC keeps holding out for more news and hype to come out so they can get the stock price back up and not have to worsen the financing terms. I believe PKC will be filing their application for an Association Contract next week. Hopefully this is an event which is "announceable" and once that is announced Mike Strain can talk about that prospect in the PKC report he's putting together. Then when PKC goes to the Strain/Westergaard O&G Microcap Conference on 1/15 they will have something to talk about other than the Alcaravan play. This is critical because if you just look at the Alcaravan play the better buy is ROH, even with them at $2 and PKC at $1.50. The other potential big upside here is that with Paul Hayes now at Yorkton and Yorkton being PKC's "sponsor", it will be very powerful when Yorkton puts out a detailed research report on PKC, with his name on it. I've lost track of the timing on this but my guess would be it will get out right after the news on the Estero #3 is announced. They will be able to wait that long to put it out because there is likely to be substantial "selling on the news" with PKC as soon as the Estero #3 results are out. So the thinking is, why not hold off, and make the report much more powerful because you can put in that they just hit a 10,000 bod well (cross your fingers!). Did you see that ROH jumped up 33% on their being listed on the TSE? Wonder if PKC will take this cue from their cousins and get listed there also. A happy New Year to you also!